Report Scope & Overview:
The White Biotechnology Market Size was valued at USD 408.90 billion in 2022, and is expected to reach USD 908.91 billion by 2030 and grow at a CAGR of 10.5% over the forecast period 2023-2030.
This is the focus of an entire branch of biotechnology known as 'white biotechnology.' It synthesises products that are easily degradable, take less energy, and produce less waste using living cells (from yeast, moulds, bacteria, and plants) and enzymes. This is not a new trend; in fact, biotechnology has long played a role in industrial operations. Bacterial enzymes have long been employed in food processing and as active ingredients in laundry detergents to avoid the need of artificial surfactants. In large-scale fermentation tanks, transgenic Escherichia coli are utilised to manufacture human insulin.
To get more information on White Biotechnology Market - Request Sample Report
Green product demand is on the rise.
Government measures to promote white biotechnology are increasing.
Traditional meals and fuels are preferred by consumers.
Biofuels are likely to rise at a fast pace as investment increases.
Microorganisms are also predicted to synthesise nanomaterials.
IMPACT OF COVID-19
In terms of innovation in the pharmaceutical sector, the global COVID-19 pandemic had a substantial impact on the white biotechnology market, indicating a profitable market growth of the category. Because of lockdowns, travel bans, and business shutdowns, the COVID-19 has impacted economies and businesses in a number of countries. The closure of numerous plants and factories has had a severe influence on global supply chains, affecting production, timely delivery, and product sales. Some few companies have already stated that goods delivery may be delayed and that future sales may suffer. The article looks at the current and future effects of the COVID-19 pandemic on the broader market, providing more accurate and trustworthy predictions based on current market conditions. Moreover, global travel bans enacted by European, Asian, and North American countries are harmeding prospects for commercial cooperation and alliances.
Biofuels, biochemicals, and biopolymers are the three main product categories in the global market. Biofuels derived from white biotechnology account for a sizable revenue proportion. Biofuels include such things as bioethanol and biodiesel. Over the projection period, rising usage of biodiesel in its pure form in the automobile industry, particularly in the United States and Europe, to reduce particulates, hydrocarbons, and carbon monoxide, is predicted to fuel demand.
White biotechnology is commonly used to make bioethanol. It is mostly used as a fuel to increase vehicle efficiency and as a gasoline additive to increase a vehicle's octane rating. Over the projection period, the automotive sector, particularly in Germany, is likely to boost process demand.
The key catalyst for the expansion of the biochemical market was the global transition to bio-economy to minimize production costs and raw material costs. Several chemical companies are attempting to lessen their reliance on fossil-based oil as the primary raw source for chemical manufacturing. This recent improvement in biomass polymer synthesis technology has created profitable chances in the biochemicals sector. Biochemicals are widely used in personal care goods, food, coatings, textiles, and other industries.
Over the forecast period, rising technological use in the manufacturing of biopharmaceuticals, notably antibodies for cancer treatment, which cannot be generated via chemical synthesis, is likely to drive demand. Furthermore, enzymes used in this technique enable the generation of chiral molecules and other difficult-to-synthesis intermediates like active medicinal components (API). Over the next eight years, the pharmaceutical industry's expansion, notably in Europe, is predicted to propel the market.
The field of bioenergy application was the most popular. Efforts by major economic development companies, such as North America and Europe, to develop various clean energy sources to meet growing demand and reduce reliance on oil-producing countries to reduce the cost of importing fuel are expected to have a positive impact on the white biotechnology process.
With the development of dietary supplements, the use of many of the enzymes and compounds found in white biotechnology has greatly increased. Demand for white biotechnology in food systems and feed additives is expected to grow due to the high performance of white-based biotechnology products combined with outstanding biocompatibility compliance.
KEY MARKET SEGMENTATION:
Food and Beverages
Need any customization research on White Biotechnology Market - Enquiry Now
This technology's greatest regional market is now North America. The government's significant support for R&D in the sector, as well as the growing consumer demand for raw materials and chemicals, has strengthened North America's position in the global market.
Enzymes are an integral part of current efforts in Europe and the United States to harvest and use biomass as a feed supply for the production of high value biofuels, biopolymers, and biological chemicals from renewable resources. The growing use of biomass instead of petroleum is predicted to have a positive impact on the environment, fuel economy growth, and reduce further dependence on petroleum sales, all of which will drive the need for technology during the forecast period.
The healthy growth of the chemical industry has created a significant need for highly efficient compounds made from renewable feedstock. As a result, the demand for biochemical chemicals has increased throughout Europe in recent years. Part of the biochemical product is expected to be of great benefit to the European biotechnology industry.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players of the White Biotechnology Market are as follows: Archer Daniels Midland Company, Koninklijke DSM N.V, BASF SE, Cargill, Inc., McKesson Corporation, Corbion N.V., Le saffre, Novozymes, GE Healthcare, Fujifilm Holdings Corporation and Other Players
|Market Size in 2022||US$ 408.90 Billion|
|Market Size by 2030||US$ 908.91 Billion|
|CAGR||CAGR of 10.5% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Biomaterials, Biochemicals, Biofuels, Industrial Enzymes)
• By Application (Chemicals, Food and Beverages, Pharmaceuticals, Feed)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Archer Daniels Midland Company, Koninklijke DSM N.V, BASF SE, Cargill, Inc., McKesson Corporation, Corbion N.V., Le saffre, Novozymes, GE Healthcare, Fujifilm Holdings Corporation.|
|DRIVERS||• Green product demand is on the rise.
• Government measures to promote white biotechnology are increasing.
|RESTRAINTS||• Traditional meals and fuels are preferred by consumers.|
Ans: The White Biotechnology Market Size was valued at USD 408.90 billion in 2022.
Ans: The White Biotechnology Market is to grow at a CAGR of 10.5% over the forecast period 2023-2030.
With the greatest revenue share, North America dominated the overall White Biotechnology market.
Yes, this report covers qualitative and quantitative analysis.
White Biotechnology market is divided in two segments and they are by type, and by application.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
22.214.171.124 United Kingdom
126.96.36.199 South Korea
188.8.131.52 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. White Biotechnology Market Segmentation, By Type
8.4 Industrial Enzymes
9. White Biotechnology Market Segmentation, By Application
9.2 Food and Beverages
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11. Company Profiles
11.1 Archer Daniels Midland Company
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Koninklijke DSM N.V
11.3 BASF SE
11.4 Cargill, Inc.
11.5 McKesson Corporation
11.6 Corbion N.V.
11.7 Le saffre, Novozymes
11.8 GE Healthcare
11.9 Fujifilm Holdings Corporation
11.10 Philips Healthcare
12. Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share Analysis
12.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Magnetic Resonance Imaging (MRI) Market was valued at USD 5.4 Bn in 2022 and is expected to reach USD 8.93 Bn by 2030 and grow at a CAGR of 6.5% during the forecasted period 2023-2030.
In 2022, The Smart Contact Lenses Market size amounted to USD 445.28 Million & is estimated to reach USD 6098.80 Million by 2030 and increase at a compound annual growth rate of 38.7% between 2023 and 2030.
The Irritable Bowel Syndrome Treatment Market Size was valued at USD 1.47 billion in 2022, and is expected to reach USD 2.81 billion by 2030, and grow at a CAGR of 8.4% over the forecast period 2023-2030.
The Menstrual Cup Market Size was valued at USD 785.13 million in 2022, and is expected to reach USD 1204.9 million by 2030 and grow at a CAGR of 5.5% over the forecast period 2023-2030.
The Veterinary Imaging Market size was USD 1.85 Billion in 2022 and is expected to Reach USD 3.09 Billion by 2030 and grow at a CAGR of 6.64% over the forecast period of 2023-2030.
The Digital Clinical Trials Market was valued at USD 7.94 billion in 2022 and is expected to reach at USD 12.56 billion in 2030, and grow at a CAGR of 5.9% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone